File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3390/ijms241411708
- Scopus: eid_2-s2.0-85166007467
- WOS: WOS:001035938800001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection
Title | Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection |
---|---|
Authors | |
Keywords | bismuth H. pylori next generation sequencing NGS stool based-PCR vonoprazan |
Issue Date | 20-Jul-2023 |
Publisher | MDPI |
Citation | International Journal of Molecular Sciences, 2023, v. 24, n. 14 How to Cite? |
Abstract | Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe, ongoing efforts are still needed to optimize current and future regimens in view of the increasing antibiotic resistance. The resistance of H. pylori to different antibiotics is caused by different molecular mechanisms, and advancements in sequencing technology have come a far way in broadening our understanding and in facilitating the testing of antibiotic susceptibility to H. pylori. In this literature review, we give an overview of the molecular mechanisms behind resistance, as well as discuss and compare different antibiotic susceptibility tests based on the latest research. We also discuss the principles of antibiotic stewardship and compare the performance of empirical therapies based on up-to-date resistance patterns and susceptibility-guided therapies in providing effective H. pylori treatment. Studies and clinical guidelines should ensure that the treatment being tested or recommended can reliably achieve a pre-agreed acceptable level of eradication rate and take into account the variations in antibiotic resistance across populations. Local, regional and international organizations must work together to establish routine antibiotic susceptibility surveillance programs and enforce antibiotic stewardship in the treatment of H. pylori, so that it can be managed in a sustainable and efficient manner. |
Persistent Identifier | http://hdl.handle.net/10722/331364 |
ISSN | 2023 Impact Factor: 4.9 2023 SCImago Journal Rankings: 1.179 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ng, Ho Yu | - |
dc.contributor.author | Leung, Wai K | - |
dc.contributor.author | Cheung, Ka Shing | - |
dc.date.accessioned | 2023-09-21T06:55:05Z | - |
dc.date.available | 2023-09-21T06:55:05Z | - |
dc.date.issued | 2023-07-20 | - |
dc.identifier.citation | International Journal of Molecular Sciences, 2023, v. 24, n. 14 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | http://hdl.handle.net/10722/331364 | - |
dc.description.abstract | <p>Despite the declining trend of <em>Helicobacter pylori</em> (<em>H. pylori</em>) prevalence around the globe, ongoing efforts are still needed to optimize current and future regimens in view of the increasing antibiotic resistance. The resistance of <em>H. pylori</em> to different antibiotics is caused by different molecular mechanisms, and advancements in sequencing technology have come a far way in broadening our understanding and in facilitating the testing of antibiotic susceptibility to <em>H. pylori</em>. In this literature review, we give an overview of the molecular mechanisms behind resistance, as well as discuss and compare different antibiotic susceptibility tests based on the latest research. We also discuss the principles of antibiotic stewardship and compare the performance of empirical therapies based on up-to-date resistance patterns and susceptibility-guided therapies in providing effective <em>H. pylori</em> treatment. Studies and clinical guidelines should ensure that the treatment being tested or recommended can reliably achieve a pre-agreed acceptable level of eradication rate and take into account the variations in antibiotic resistance across populations. Local, regional and international organizations must work together to establish routine antibiotic susceptibility surveillance programs and enforce antibiotic stewardship in the treatment of <em>H. pylori</em>, so that it can be managed in a sustainable and efficient manner.<br></p> | - |
dc.language | eng | - |
dc.publisher | MDPI | - |
dc.relation.ispartof | International Journal of Molecular Sciences | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | bismuth | - |
dc.subject | H. pylori | - |
dc.subject | next generation sequencing | - |
dc.subject | NGS | - |
dc.subject | stool based-PCR | - |
dc.subject | vonoprazan | - |
dc.title | Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/ijms241411708 | - |
dc.identifier.scopus | eid_2-s2.0-85166007467 | - |
dc.identifier.volume | 24 | - |
dc.identifier.issue | 14 | - |
dc.identifier.eissn | 1422-0067 | - |
dc.identifier.isi | WOS:001035938800001 | - |
dc.identifier.issnl | 1422-0067 | - |